Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2775 of 3284 entries
View as:

Connection Between General Practitioner's (GP's) Estimation of Cardiovascular Risk and Theoretical Calculation in France

Phase: N/A Priority: Normal
NCT ID: NCT01039402 Org: User:
Start: 12/31/09 End: 01/31/10 Due: 01/31/11

Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)

Phase: N/A Priority: Normal
NCT ID: NCT00163527 Org: User:
Start: 04/30/03 End: 11/30/05 Due: 11/30/06

A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00757848 Org: User:
Start: 10/31/08 End: 08/31/09 Due: 08/31/10

Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)

Phase: N/A Priority: Normal
NCT ID: NCT00899470 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide

Phase: N/A Priority: Normal
NCT ID: NCT00608153 Org: User:
Start: 01/31/07 End: 09/30/07 Due: 09/30/08

KOREA Study (Korea Osimertinib Real World Evidence Study to Assess Safety and Efficacy)

Phase: N/A Priority: Normal
NCT ID: NCT02777567 Org: User:
Start: 09/29/16 End: 03/19/20 Due: 03/19/21

AZD7687 Multiple Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT01119352 Org: User:
Start: 04/30/10 End: 03/31/11 Due: 03/31/12

Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)

Phase: N/A Priority: Normal
NCT ID: NCT02796651 Org: User:
Start: 06/30/16 End: 12/07/16 Due: 12/07/17

A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone

Phase: N/A Priority: Normal
NCT ID: NCT02419612 Org: User:
Start: 08/14/15 End: 09/18/19 Due: 09/18/20

A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg

Phase: N/A Priority: Normal
NCT ID: NCT02091986 Org: User:
Start: 04/30/14 End: 04/30/16 Due: 04/30/17

Effect of Ketoconazole on Biliary Excretion of AZD0837

Phase: N/A Priority: Normal
NCT ID: NCT00812344 Org: User:
Start: 12/31/08 End: 03/31/09 Due: 03/31/10

Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT01215058 Org: User:
Start: 10/31/10 End: 04/30/11 Due: 04/30/12

A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04210388 Org: User:
Start: 01/14/20 End: 03/09/20 Due: 03/09/21

A Study of Benralizumab in Patients With Eosinophilic Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT04543409 Org: User:
Start: 09/22/20 End: 02/06/23 Due: 02/06/24

Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations

Phase: N/A Priority: Normal
NCT ID: NCT00272753 Org: User:
Start: 04/30/04 End: 11/30/05 Due: 11/30/06

Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)

Phase: N/A Priority: Normal
NCT ID: NCT00577824 Org: User:
Start: 01/31/08 End: 11/30/08 Due: 11/30/09

A Study to Compare Bioavailability of AZD5055 Film-coated Tablet With AZD5055 Oral Suspension and to Assess the Effect of Food and an Acid Reducing Agent on Pharmacokinetics (PK) of AZD5055 in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT05630677 Org: User:
Start: 11/04/22 End: 02/09/23 Due: 02/09/24

Study to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02908750 Org: User:
Start: 03/02/17 End: 10/11/22 Due: 10/11/23

Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1940

Phase: N/A Priority: Normal
NCT ID: NCT00689780 Org: User:
Start: 03/31/08 End: 11/30/08 Due: 11/30/09

Dose Rate Range Finding Study of Propofol for minimal-to Moderate Sedation on Upper & Lower Endoscopic Tests

Phase: N/A Priority: Normal
NCT ID: NCT01189604 Org: User:
Start: 08/31/10 End: 11/30/10 Due: 11/30/11

A Phase I Study to Assess PK of AZD7986 Alone & With Verapamil, Itraconazole or Diltiazem in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02653872 Org: User:
Start: 01/22/16 End: 04/13/16 Due: 04/13/17

Egypt Hypertension Study

Phase: N/A Priority: Normal
NCT ID: NCT02604771 Org: User:
Start: 04/03/16 End: 02/14/18 Due: 02/14/19

Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT06350123 Org: User:
Start: 05/01/24 End: 05/09/25 Due: 05/09/26

A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04739761 Org: User:
Start: 06/22/21 End: 02/03/26 Due: 02/03/27

Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004

Phase: N/A Priority: Normal
NCT ID: NCT06813781 Org: User:
Start: 12/19/24 End: 10/21/25 Due: 10/21/26